News
Stay up-to-date on the most trending topics in crypto with our professional and in-depth news.
VIPBitget VIP Weekly Research InsightsThe Solana ecosystem has shown remarkable performance this year. The 24-hour trading volume on Solana's DEXs frequently surpasses that of Ethereum, and the SOL/ETH exchange rate has steadily risen. Coinbase's recent Q3 earnings report revealed that SOL now accounts for 11% of its trading revenue, highlighting users' strong interest in trading SOL. During this market cycle, it can be advantageous to hold SOL positions. Additionally, holding SOL-based LSTs allows you to earn annualized returns that are denominated in SOL. Bitget has partnered with Solayer, Orca, Save, and Kamino to launch BGSOL, and will work to expand BGSOL's applications. With the support from Bitget, BGSOL currently offers the highest APR among SOL-based LSTs.
VIPBitget VIP Weekly Research InsightsThe AI agent concept has recently gained significant traction in the crypto space, particularly AI agent memecoins. Moving beyond theoretical ideas, AI agents are now being applied across various fields, including autonomous execution of transactions on the blockchain, complex analytics, and even automating everyday tasks. Overall, the AI agent trend in crypto demonstrates considerable growth potential and technological innovation. However, investors and tech enthusiasts are advised to balance enthusiasm with rational assessment, focusing on genuine progress and practical applications of these projects. This articles recommends two projects, VIRTUAL and OLAS, both showcasing substantial advancements and real-world use cases with strong market support.
- 12:32The attacker of Polterfinance has sent 2600 ETH to Tornado.Cash since November 19thAccording to CertiK monitoring, the attacker of polterfinance has sent 2600 ETH to Tornado.Cash since November 19.
- 12:32The board of directors of the U.S. listed company Enlivex Therapeutics has approved the purchase of one million dollars in Bitcoin as a reserve assetAccording to Globenewswire, the US-listed company Enlivex Therapeutics Ltd. (Nasdaq: ENLV) announced yesterday that its board of directors has approved the purchase of up to $1 million in Bitcoin as part of its cash management strategy. Enlivex CEO Oren Hershkovitz said: "With the growing demand for Bitcoin and its increasing acceptance as a recognized medium of exchange, we believe that Bitcoin will become a strong and diversified reserve asset for the company. With the recent approval of Bitcoin ETFs and increasing support from institutional investors, we believe that Bitcoin can provide potential functional value storage for the company and hedge against inflation in standard currencies." Enlivex is described as a clinical-stage macrophage reprogramming immunotherapy company.
- 12:15Data: Bitcoin's market share reaches 61.84%, setting a new high in this bull market roundAccording to TradingView data, as Bitcoin breaks through $98,000 and continues to refresh its historical high price, the market share of Bitcoin (BTC.D) has risen to 61.84%, also setting a new record since this bull market.
